Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study of Sequential Combination Therapy With Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B

NCT03357822 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03357822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03357822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study of Sequential Combination Therapy With Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 25, 2018
Completion date
July 25, 2022
Enrollment
2,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b